Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. The REMAP-CAP Investigators New England Journal of Medicine, February, 2021.
Paper doi bibtex 1 download @article{the_remap-cap_investigators_interleukin-6_2021,
title = {Interleukin-6 {Receptor} {Antagonists} in {Critically} {Ill} {Patients} with {Covid}-19},
issn = {0028-4793, 1533-4406},
url = {http://www.nejm.org/doi/10.1056/NEJMoa2100433},
doi = {10.1056/NEJMoa2100433},
language = {en},
urldate = {2021-02-28},
journal = {New England Journal of Medicine},
author = {{The REMAP-CAP Investigators}},
month = feb,
year = {2021},
pages = {NEJMoa2100433},
}
Downloads: 1
{"_id":"uKqxEyQTBj3WSJsfd","bibbaseid":"theremapcapinvestigators-interleukin6receptorantagonistsincriticallyillpatientswithcovid19-2021","authorIDs":[],"author_short":["The REMAP-CAP Investigators"],"bibdata":{"bibtype":"article","type":"article","title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19","issn":"0028-4793, 1533-4406","url":"http://www.nejm.org/doi/10.1056/NEJMoa2100433","doi":"10.1056/NEJMoa2100433","language":"en","urldate":"2021-02-28","journal":"New England Journal of Medicine","author":[{"firstnames":[],"propositions":[],"lastnames":["The REMAP-CAP Investigators"],"suffixes":[]}],"month":"February","year":"2021","pages":"NEJMoa2100433","bibtex":"@article{the_remap-cap_investigators_interleukin-6_2021,\n\ttitle = {Interleukin-6 {Receptor} {Antagonists} in {Critically} {Ill} {Patients} with {Covid}-19},\n\tissn = {0028-4793, 1533-4406},\n\turl = {http://www.nejm.org/doi/10.1056/NEJMoa2100433},\n\tdoi = {10.1056/NEJMoa2100433},\n\tlanguage = {en},\n\turldate = {2021-02-28},\n\tjournal = {New England Journal of Medicine},\n\tauthor = {{The REMAP-CAP Investigators}},\n\tmonth = feb,\n\tyear = {2021},\n\tpages = {NEJMoa2100433},\n}\n\n","author_short":["The REMAP-CAP Investigators"],"key":"the_remap-cap_investigators_interleukin-6_2021","id":"the_remap-cap_investigators_interleukin-6_2021","bibbaseid":"theremapcapinvestigators-interleukin6receptorantagonistsincriticallyillpatientswithcovid19-2021","role":"author","urls":{"Paper":"http://www.nejm.org/doi/10.1056/NEJMoa2100433"},"metadata":{"authorlinks":{}},"downloads":1},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/NYG2RI7X/items?key=hSjrOPQRRHHWY81SKs6CEz45&format=bibtex&limit=100","creationDate":"2021-02-28T20:52:52.334Z","downloads":1,"keywords":[],"search_terms":["interleukin","receptor","antagonists","critically","ill","patients","covid","the remap-cap investigators"],"title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19","year":2021,"dataSources":["Yzu7qsRzR9ZEfFmbJ","ydy8iPhP2TsFttgY7","KWJj8zsJW4ML2G243","6SkqXiGdfnEhkfeWg","gYp5LQXkoiKhbuLwC","BvvFw2zRfGrfhQ6x4","ZJ4j4Apddh3MpQnDj"]}